scispace - formally typeset
Journal ArticleDOI

Technologies for label-free separation of circulating tumor cells: from historical foundations to recent developments

TLDR
This review reviews biophysical label-free technologies that have been developed for CTC separation, including techniques based on filtration, hydrodynamic chromatography, and dielectrophoresis and discusses requirements for subsequent characterization of CTCs.
Abstract
Circulating tumor cells (CTCs) are malignant cells shed into the bloodstream from a tumor that have the potential to establish metastases in different anatomical sites. The separation and subsequent characterization of these cells is emerging as an important tool for both biomarker discovery and the elucidation of mechanisms of metastasis. Established methods for separating CTCs rely on biochemical markers of epithelial cells that are known to be unreliable because of epithelial-to-mesenchymal transition, which reduces expression for epithelial markers. Emerging label-free separation methods based on the biophysical and biomechanical properties of CTCs have the potential to address this key shortcoming and present greater flexibility in the subsequent characterization of these cells. In this review we first present what is known about the biophysical and biomechanical properties of CTCs from historical studies and recent research. We then review biophysical label-free technologies that have been developed for CTC separation, including techniques based on filtration, hydrodynamic chromatography, and dielectrophoresis. Finally, we evaluate these separation methods and discuss requirements for subsequent characterization of CTCs.

read more

Citations
More filters
Journal ArticleDOI

Circulating tumor cell technologies

TL;DR: As the understanding of CTC biology matures, CTC technologies will need to evolve, and some of the present challenges facing the field are discussed in light of recent data encompassing epithelial‐to‐mesenchymal transition, tumor‐initiating cells, and CTC clusters.
Journal ArticleDOI

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility

TL;DR: This review focuses on the opportunities as well as the challenges that should be addressed so that these tools may eventually be implemented into routine clinical care.
Journal ArticleDOI

Rare cell isolation and analysis in microfluidics

TL;DR: The design considerations of representative microfluidic devices for rare cell isolation and analysis and a perspective on the development trends and promising research directions in this field are proposed.
Journal ArticleDOI

Emerging Role of Nanomaterials in Circulating Tumor Cell Isolation and Analysis

TL;DR: The nanoscale provides a new set of tools that has the potential to overcome current limitations associated with CTC capture and analysis, allowing the improvements necessary to further CTC research.
Journal ArticleDOI

Isolation of circulating tumor cells by dielectrophoresis.

TL;DR: The force equilibrium method of dielectrophoretic field-flow fractionation (DEP-FFF) is shown to offer higher discrimination and throughput than earlier DEP trapping methods and to be applicable to clinical studies.
References
More filters
Journal ArticleDOI

Isolation of rare circulating tumour cells in cancer patients by microchip technology.

TL;DR: The CTC-chip successfully identified CTCs in the peripheral blood of patients with metastatic lung, prostate, pancreatic, breast and colon cancer in 115 of 116 samples, with a range of 5–1,281CTCs per ml and approximately 50% purity.
Journal ArticleDOI

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

TL;DR: Owing to the importance of these tumour-associated phenotypes in metastasis and cancer-related mortality, targeting the products of such cellular plasticity is an attractive but challenging approach that is likely to lead to improved clinical management of cancer patients.
Journal ArticleDOI

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.

TL;DR: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs, which are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.
Journal ArticleDOI

Optical trapping and manipulation of single cells using infrared laser beams

TL;DR: The use of infrared (IR) light is used to make much improved laser traps with significantly less optical damage to a variety of living cells, and new manipulative techniques using IR light are capable of producing large forces under damage-free conditions and improve the prospects for wider use of optical manipulation techniques in microbiology.
Journal ArticleDOI

Nanomechanical analysis of cells from cancer patients

TL;DR: This work reports the stiffness of live metastatic cancer cells taken from the body fluids of patients with suspected lung, breast and pancreas cancer, and shows that nanomechanical analysis correlates well with immunohistochemical testing currently used for detecting cancer.
Related Papers (5)